Cargando…
Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms
BACKGROUND: Identification of Hürthle cell cancers by non-operative fine-needle aspiration biopsy (FNAB) of thyroid nodules is challenging. Resultingly, non-cancerous Hürthle lesions were conventionally distinguished from Hürthle cell cancers by histopathological examination of tissue following surg...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450053/ https://www.ncbi.nlm.nih.gov/pubmed/30952205 http://dx.doi.org/10.1186/s12918-019-0693-z |
_version_ | 1783408974623670272 |
---|---|
author | Hao, Yangyang Duh, Quan-Yang Kloos, Richard T. Babiarz, Joshua Harrell, R. Mack Traweek, S. Thomas Kim, Su Yeon Fedorowicz, Grazyna Walsh, P. Sean Sadow, Peter M. Huang, Jing Kennedy, Giulia C. |
author_facet | Hao, Yangyang Duh, Quan-Yang Kloos, Richard T. Babiarz, Joshua Harrell, R. Mack Traweek, S. Thomas Kim, Su Yeon Fedorowicz, Grazyna Walsh, P. Sean Sadow, Peter M. Huang, Jing Kennedy, Giulia C. |
author_sort | Hao, Yangyang |
collection | PubMed |
description | BACKGROUND: Identification of Hürthle cell cancers by non-operative fine-needle aspiration biopsy (FNAB) of thyroid nodules is challenging. Resultingly, non-cancerous Hürthle lesions were conventionally distinguished from Hürthle cell cancers by histopathological examination of tissue following surgical resection. Reliance on histopathological evaluation requires patients to undergo surgery to obtain a diagnosis despite most being non-cancerous. It is highly desirable to avoid surgery and to provide accurate classification of benignity versus malignancy from FNAB preoperatively. In our first-generation algorithm, Gene Expression Classifier (GEC), we achieved this goal by using machine learning (ML) on gene expression features. The classifier is sensitive, but not specific due in part to the presence of non-neoplastic benign Hürthle cells in many FNAB. RESULTS: We sought to overcome this low-specificity limitation by expanding the feature set for ML using next-generation whole transcriptome RNA sequencing and called the improved algorithm the Genomic Sequencing Classifier (GSC). The Hürthle identification leverages mitochondrial expression and we developed novel feature extraction mechanisms to measure chromosomal and genomic level loss-of-heterozygosity (LOH) for the algorithm. Additionally, we developed a multi-layered system of cascading classifiers to sequentially triage Hürthle cell-containing FNAB, including: 1. presence of Hürthle cells, 2. presence of neoplastic Hürthle cells, and 3. presence of benign Hürthle cells. The final Hürthle cell Index utilizes 1048 nuclear and mitochondrial genes; and Hürthle cell Neoplasm Index leverages LOH features as well as 2041 genes. Both indices are Support Vector Machine (SVM) based. The third classifier, the GSC Benign/Suspicious classifier, utilizes 1115 core genes and is an ensemble classifier incorporating 12 individual models. CONCLUSIONS: The accurate algorithmic depiction of this complex biological system among Hürthle subtypes results in a dramatic improvement of classification performance; specificity among Hürthle cell neoplasms increases from 11.8% with the GEC to 58.8% with the GSC, while maintaining the same sensitivity of 89%. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12918-019-0693-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6450053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64500532019-04-16 Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms Hao, Yangyang Duh, Quan-Yang Kloos, Richard T. Babiarz, Joshua Harrell, R. Mack Traweek, S. Thomas Kim, Su Yeon Fedorowicz, Grazyna Walsh, P. Sean Sadow, Peter M. Huang, Jing Kennedy, Giulia C. BMC Syst Biol Research BACKGROUND: Identification of Hürthle cell cancers by non-operative fine-needle aspiration biopsy (FNAB) of thyroid nodules is challenging. Resultingly, non-cancerous Hürthle lesions were conventionally distinguished from Hürthle cell cancers by histopathological examination of tissue following surgical resection. Reliance on histopathological evaluation requires patients to undergo surgery to obtain a diagnosis despite most being non-cancerous. It is highly desirable to avoid surgery and to provide accurate classification of benignity versus malignancy from FNAB preoperatively. In our first-generation algorithm, Gene Expression Classifier (GEC), we achieved this goal by using machine learning (ML) on gene expression features. The classifier is sensitive, but not specific due in part to the presence of non-neoplastic benign Hürthle cells in many FNAB. RESULTS: We sought to overcome this low-specificity limitation by expanding the feature set for ML using next-generation whole transcriptome RNA sequencing and called the improved algorithm the Genomic Sequencing Classifier (GSC). The Hürthle identification leverages mitochondrial expression and we developed novel feature extraction mechanisms to measure chromosomal and genomic level loss-of-heterozygosity (LOH) for the algorithm. Additionally, we developed a multi-layered system of cascading classifiers to sequentially triage Hürthle cell-containing FNAB, including: 1. presence of Hürthle cells, 2. presence of neoplastic Hürthle cells, and 3. presence of benign Hürthle cells. The final Hürthle cell Index utilizes 1048 nuclear and mitochondrial genes; and Hürthle cell Neoplasm Index leverages LOH features as well as 2041 genes. Both indices are Support Vector Machine (SVM) based. The third classifier, the GSC Benign/Suspicious classifier, utilizes 1115 core genes and is an ensemble classifier incorporating 12 individual models. CONCLUSIONS: The accurate algorithmic depiction of this complex biological system among Hürthle subtypes results in a dramatic improvement of classification performance; specificity among Hürthle cell neoplasms increases from 11.8% with the GEC to 58.8% with the GSC, while maintaining the same sensitivity of 89%. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12918-019-0693-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-05 /pmc/articles/PMC6450053/ /pubmed/30952205 http://dx.doi.org/10.1186/s12918-019-0693-z Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hao, Yangyang Duh, Quan-Yang Kloos, Richard T. Babiarz, Joshua Harrell, R. Mack Traweek, S. Thomas Kim, Su Yeon Fedorowicz, Grazyna Walsh, P. Sean Sadow, Peter M. Huang, Jing Kennedy, Giulia C. Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms |
title | Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms |
title_full | Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms |
title_fullStr | Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms |
title_full_unstemmed | Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms |
title_short | Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms |
title_sort | identification of hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450053/ https://www.ncbi.nlm.nih.gov/pubmed/30952205 http://dx.doi.org/10.1186/s12918-019-0693-z |
work_keys_str_mv | AT haoyangyang identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT duhquanyang identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT kloosrichardt identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT babiarzjoshua identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT harrellrmack identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT traweeksthomas identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT kimsuyeon identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT fedorowiczgrazyna identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT walshpsean identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT sadowpeterm identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT huangjing identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms AT kennedygiuliac identificationofhurthlecellcancerssolvingaclinicalchallengewithgenomicsequencingandatrioofmachinelearningalgorithms |